Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CardieX ( (AU:CQT) ) has issued an update.
CONNEQT Health reported a strong December 2025 quarter, with Pulse consumer device revenue and unit sales growing more than 200% quarter-on-quarter to exceed A$1.1 million, driven by disciplined pricing, marketing execution and peak-season demand. The company’s shift to a lower upfront device price and new in-app monetisation, including the Care+ subscription and report bundles, is gaining traction, with notable early adoption and retention supporting a transition toward recurring consumer revenue and enabling a subsequent increase in the Pulse price without dampening sales momentum. On the enterprise side, CONNEQT is converting clinical pilots into multi-year, consumption-based contracts, marking a strategic move away from one-off capital equipment sales toward recurring, software-enabled clinical revenue and opening access to clinics that could not accommodate high upfront costs. Supported by improving unit economics, operational leverage, and a strengthened balance sheet via a A$3.1 million institutional placement that left it with A$2.4 million in cash at quarter-end, the company enters the next quarter with increased scale, a Pulse annualised revenue run-rate above US$4.0 million and clearer visibility on recurring revenue streams across both consumer and enterprise channels.
More about CardieX
CONNEQT Health (ASX: CQT) operates in the digital health and medical technology industry, focusing on arterial health insights delivered through connected consumer devices and software-enabled clinical solutions. Its flagship consumer product, the Pulse device, targets health-conscious consumers seeking cardiology-grade data, while its enterprise platform serves clinics through recurring, usage-based models that replace traditional upfront capital equipment sales. The company’s market focus spans both direct-to-consumer channels and healthcare providers, with an emphasis on recurring revenue from subscriptions, in-app purchases, and clinical software usage.
Average Trading Volume: 585,224
Technical Sentiment Signal: Sell
Current Market Cap: A$27.56M
See more data about CQT stock on TipRanks’ Stock Analysis page.